SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-042540
Filing Date
2023-11-22
Accepted
2023-11-22 18:28:27
Documents
1
Period of Report
2023-11-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10841
  Complete submission text file 0001493152-23-042540.txt   13439
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address
SAXENA PARAG (Reporting) CIK: 0001015823 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38634 | Film No.: 231434714

Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 212-710-5220
VEDANTA PARTNERS, LLC (Reporting) CIK: 0001502216 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38634 | Film No.: 231434716

Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 212-710-5220
VEDANTA ASSOCIATES, L.P. (Reporting) CIK: 0001502222 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38634 | Film No.: 231434715

Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations